Kingfa Science

Which are the latest news on Kingfa Science?

Why is Kingfa Science & Technology (India) Ltd falling/rising?

As of 23-Jun, Kingfa Science & Technology (India) Ltd's stock price has risen to Rs 5,153.50, up 1.75%, driven by strong performance metrics and financial health, including a low debt-to-equity ratio and record quarterly sales. Despite a drop in delivery volume, the stock continues to attract positive market sentiment and investor confidence.

As of 23-Jun, Kingfa Science & Technology (India) Ltd is experiencing a rise in its stock price, currently at Rs 5,153.50, reflecting an increase of Rs 88.4 or 1.75%. This upward movement can be attributed to several factors highlighted in the recent performance data. <BR><BR>The stock has shown strong performance against the benchmark Sensex, outperforming it by 2.35% today. Over the past year, Kingfa Science & Technology has delivered impressive returns of 68.13%, significantly surpassing the Sensex's decline of 6.96% during the same period. Additionally, the stock has demonstrated remarkable growth over the long term, with a 3-year return of 159.06% and a 5-year return of 395.93%, indicating a consistent upward trend.<BR><BR>The company's financial health is also a contributing factor to the stock's rise. With a low debt-to-equity ratio of 0.04 times, Kingfa Science & Technology is positioned well for long-term growth. The recent quarterly results show record net sales of Rs 578.47 crore and an operating profit margin of 14%, further bolstering investor confidence.<BR><BR>Despite a decrease in delivery volume by 42% against the 5-day average, the stock remains liquid enough for trading, which suggests that while investor participation has fallen, the overall market sentiment towards the stock remains positive. The stock's performance today, including reaching an intraday high of Rs 5,251.9, reflects strong market interest and confidence in the company's future prospects.

How big is Kingfa Science?

As of 10th June, Kingfa Science & Technology (India) Ltd has a market capitalization of 7,078.00 Cr, with recent net sales of 1,995.55 Cr and net profit of 185.25 Cr over the last four quarters.

As of 10th June, <BR><BR>Market Cap: Kingfa Science & Technology (India) Ltd has a market capitalization of 7,078.00 Cr, categorizing it as a Small Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 1,995.55 Cr, while the sum of Net Profit for the same period is 185.25 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the balance sheet is March 2025. Shareholder's Funds are valued at 728.61 Cr, and Total Assets amount to 1,155.62 Cr.

Who are in the management team of Kingfa Science?

The management team of Kingfa Science includes Bo Jingen, D Balaji, Wu Xiaohui (Non Independent Executive Directors), and Narayanaswamy Subramanian, Dilip Dinkar Kulkarni, Nilima Ramrao Shinde (Independent Non Executive Directors).

The management team of Kingfa Science includes the following individuals:<BR><BR>1. Bo Jingen - Non Independent Executive Director<BR>2. D Balaji - Executive Non Independent Director<BR>3. Narayanaswamy Subramanian - Independent Non Executive Director<BR>4. Dilip Dinkar Kulkarni - Independent Non Executive Director<BR>5. Nilima Ramrao Shinde - Independent Non Executive Director<BR>6. Wu Xiaohui - Non Independent Executive Director<BR><BR>If you need more details about their roles or backgrounds, feel free to ask!

Who are the peers of the Kingfa Science?

Kingfa Science's peers include Astral, Garware Hi Tech, Shaily Engineer, Finolex Inds., Time Technoplast, Prince Pipes, Apollo Pipes, Jain Irrigation, Jai Corp, and All Time Plastic. Key insights show Kingfa Science and Time Technoplast have excellent growth, while Shaily Engineer leads in 1-year returns at 69.09%, and Jain Irrigation has the lowest at -52.96%.

Peers: The peers of Kingfa Science are Astral, Garware Hi Tech, Shaily Engineer., Finolex Inds., Time Technoplast, Prince Pipes, Apollo Pipes, Jain Irrigation, Jai Corp, and All Time Plastic.<BR><BR>Quality Snapshot: Excellent management risk is observed at Astral, Finolex Inds., Shaily Engineer., Time Technoplast, and Kingfa Science, while Average management risk is found at Garware Hi Tech, Prince Pipes, and Apollo Pipes. Below Average management risk is noted for Jain Irrigation and Jai Corp. Growth is Excellent for Time Technoplast and Kingfa Science, Good for Shaily Engineer. and Jain Irrigation, while Below Average growth is seen at Astral, Garware Hi Tech, Finolex Inds., Prince Pipes, Apollo Pipes, and Jai Corp. Capital Structure is Excellent for Astral, Garware Hi Tech, Finolex Inds., and Prince Pipes, Good for Shaily Engineer., Time Technoplast, and Apollo Pipes, and Below Average for Jain Irrigation.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Shaily Engineer. at 69.09%, while the lowest is Jain Irrigation at -52.96%. Kingfa Science's 1-year return of 61.98% is significantly higher than Jain Irrigation's. Additionally, Finolex Inds., Time Technoplast, Jain Irrigation, Jai Corp, and All Time Plastic have negative six-month returns.

What does Kingfa Science do?

Kingfa Science & Technology (India) Ltd is a small-cap company in the plastic products industry, focusing on industrial applications. As of March 2026, it reported net sales of ₹578 Cr and a net profit of ₹59 Cr, with a market cap of ₹7,078 Cr.

Overview: <BR>Kingfa Science & Technology (India) Ltd operates in the plastic products industry, specifically focusing on industrial applications, and is categorized as a small-cap company.<BR><BR>History: <BR>The company was incorporated in November 1983 as 'Hydro S&S Industries Limited' and was renamed to Kingfa Science & Technology (India) Limited in December 2015. The latest quarterly results reported net sales and net profit for March 2026.<BR><BR>Financial Snapshot: <BR>Net Sales: 578 Cr (Quarterly Results - Mar 2026) <BR>Net Profit: 59 Cr (Quarterly Results - Mar 2026) <BR>Market Cap: INR 7,078 Cr (Small Cap)<BR><BR>Key Metrics: <BR>P/E: 37.00 <BR>Industry P/E: 36 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.03 <BR>Return on Equity: 25.43% <BR>Price to Book: 9.71 <BR><BR>Contact Details: <BR>Address: Dhun Building III Floor, 827 Anna Salai Chennai Tamil Nadu : 600002 <BR>Tel: 91-44-28521736 (4 lines) <BR>Email: cs@kingfaindia.com <BR>Website: http://www.hssil.com

Should I buy, sell or hold Kingfa Science & Technology (India) Ltd?

Are Kingfa Science & Technology (India) Ltd latest results good or bad?

Kingfa Science & Technology (India) Ltd's latest results are strong, with a 41.15% year-on-year increase in net profit and a 23.20% rise in revenue, indicating good financial health and operational efficiency. However, the stock's high price-to-earnings ratio raises some valuation concerns.

Kingfa Science & Technology (India) Ltd's latest results are quite strong, indicating a positive performance overall. In the fourth quarter of FY26, the company reported a net profit of ₹59.15 crores, which marks a significant increase of 41.15% year-on-year and a 30.96% improvement compared to the previous quarter. Revenue also saw robust growth, reaching ₹578.47 crores, reflecting a 23.20% year-on-year increase and an 18.19% sequential rise.<BR><BR>The operating margin improved to 14.0%, which is a multi-quarter high, showcasing enhanced operational efficiency. Additionally, the return on equity stands at a strong 23.06%, indicating effective capital utilization.<BR><BR>Despite these positive results, there are some valuation concerns, as the stock trades at a premium price-to-earnings multiple of 44x. However, the company's strong growth trajectory, with a compound annual growth rate of 26.37% in sales over the past five years, and robust institutional interest suggest that the market remains confident in its future prospects.<BR><BR>Overall, the latest results can be characterized as good, reflecting strong financial health and operational performance.

When is the next results date for Kingfa Science & Technology (India) Ltd?

The next results date for Kingfa Science & Technology (India) Ltd is 29 May 2026.

The next results date for Kingfa Science & Technology (India) Ltd is scheduled for 29 May 2026.

Is Kingfa Science overvalued or undervalued?

As of December 3, 2025, Kingfa Science is fairly valued with a PE ratio of 34.86, lower than some peers like Supreme Industries and Astral, but higher than Finolex Industries, and has delivered a strong 200% return over three years compared to the Sensex's 35.37%.

As of 3 December 2025, Kingfa Science has moved from an expensive to a fair valuation grade. The company appears to be fairly valued at this time. Key ratios include a PE ratio of 34.86, an EV to EBITDA of 23.91, and a ROE of 21.61%. <BR><BR>In comparison to peers, Kingfa Science's PE ratio is lower than Supreme Industries at 49.49 and Astral at 74.25, both of which are classified as expensive. Additionally, Finolex Industries, which is also rated fair, has a significantly lower PE ratio of 22.26, indicating that Kingfa Science is relatively more expensive than some of its peers. Despite a recent decline in stock price, Kingfa Science has shown strong long-term performance, with a 3-year return of 200% compared to the Sensex's 35.37%.

How has been the historical performance of Kingfa Science?

Kingfa Science has shown consistent growth, with net sales increasing from 627.24 Cr in Mar'21 to 1,744.69 Cr in Mar'25, and significant improvements in profitability, total assets, and cash flow. Key metrics like profit after tax rose from 5.32 Cr to 152.86 Cr during the same period, reflecting strong operational efficiency.

Answer:<BR>The historical performance of Kingfa Science shows a consistent growth trajectory in net sales and profitability over the years.<BR><BR>Breakdown:<BR>Kingfa Science has demonstrated significant growth in net sales, increasing from 627.24 Cr in Mar'21 to 1,744.69 Cr in Mar'25. This upward trend is mirrored in total operating income, which rose from 741.50 Cr in Mar'20 to 1,744.69 Cr in Mar'25. The company's operating profit (PBDIT) also saw a substantial increase, reaching 234.45 Cr in Mar'25, up from just 25.96 Cr in Mar'21. Profit before tax followed suit, climbing to 206.08 Cr in Mar'25 from 11.85 Cr in Mar'21, while profit after tax reached 152.86 Cr in Mar'25, a significant rise from 5.32 Cr in Mar'21. The company's total assets grew from 596.30 Cr in Mar'20 to 1,155.62 Cr in Mar'25, reflecting a robust expansion in its financial base. Additionally, the book value per share has increased from 287.84 in Mar'20 to 601.63 in Mar'25, indicating enhanced shareholder value. Cash flow from operating activities improved markedly, reaching 59.00 Cr in Mar'25, compared to a negative cash flow in Mar'21. Overall, Kingfa Science's financial performance illustrates a strong upward trend across key metrics, highlighting its growth and operational efficiency.

Is Kingfa Science technically bullish or bearish?

As of November 3, 2025, Kingfa Science's trend is mildly bullish, supported by a bullish MACD and moving averages, though tempered by a mildly bearish KST and Dow Theory indicators.

As of 3 November 2025, the technical trend for Kingfa Science has changed from bullish to mildly bullish. The current stance is mildly bullish, driven by a bullish MACD on both weekly and monthly time frames, along with bullish daily moving averages. However, the KST indicates a mildly bearish monthly trend, and Dow Theory shows a mildly bearish weekly stance, which tempers the overall bullish outlook. The Bollinger Bands are also mildly bullish on both weekly and monthly charts. Despite recent price fluctuations, the stock has shown strong returns over various periods, particularly in the long term.

Who are the top shareholders of the Kingfa Science?

The top shareholders of Kingfa Science include Kingfa Sci. & Tech. Co. Ltd. with 74.99%, Hongkong Victory Investment Co Limited at 6.32%, and Foreign Institutional Investors holding 6.35%. Individual investors collectively own 15.31%, while mutual funds have a minimal stake of 0.04%.

The top shareholders of Kingfa Science include the following:<BR><BR>1. **Kingfa Sci. & Tech. Co. Ltd.** - This entity holds the largest share, with a significant 74.99% stake in the company.<BR>2. **Hongkong Victory Investment Co Limited** - This is the highest public shareholder, owning 6.32% of the shares.<BR>3. **Foreign Institutional Investors (FIIs)** - A total of 6 FIIs collectively hold 6.35%.<BR>4. **Mutual Funds** - There is minimal representation from mutual funds, with just 0.04% held by one scheme.<BR>5. **Individual Investors** - They hold a combined 15.31% of the shares.<BR><BR>Overall, the majority ownership is concentrated with the promoters, particularly Kingfa Sci. & Tech. Co. Ltd.

Has Kingfa Science declared dividend?

Yes, Kingfa Science & Technology (India) Ltd has declared a 100% dividend, amounting to ₹10 per share, with an ex-date of September 17, 2024. The company has shown strong long-term performance, with a total return of 626.88% over the last 5 years.

Kingfa Science & Technology (India) Ltd has declared a 100% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 100%<BR>- Amount per share: 10<BR>- Ex-date: 17 Sep 24<BR><BR>Dividend Yield: 0.31%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -2.21%, with a dividend return of 0%, resulting in a total return of -2.21%.<BR><BR>Over the 1-year period, the price return was 65.65%, the dividend return was 0.53%, leading to a total return of 66.18%.<BR><BR>For the 2-year period, the price return was 60.17%, with a dividend return of 0.51%, culminating in a total return of 60.68%.<BR><BR>In the 3-year span, the price return reached 238.32%, while the dividend return was 1.28%, resulting in a total return of 239.6%.<BR><BR>During the 4-year period, the price return was 202.84%, with a dividend return of 1.00%, leading to a total return of 203.84%.<BR><BR>Over the last 5 years, the price return was 624.41%, and the dividend return was 2.47%, resulting in a total return of 626.88%.<BR><BR>Overall, Kingfa Science has declared a significant dividend, and while the recent returns show some volatility, the long-term performance appears strong, particularly over the 5-year period.